Results 131 to 140 of about 85,210 (198)
What do editors of medical journals think about opportunities and barriers to advancement in the publication of plain language summaries? A qualitative analysis. [PDF]
Gainey K, McCaffery K, Muscat D.
europepmc +1 more source
ABSTRACT The relationship between eco‐innovation (EI) and firm performance (FP) is central to environmental management research, yet empirical evidence remains fragmented and highly context dependent. This article presents a global systematic literature review (SLR) of 541 empirical studies (2006–April 2025) to (i) diagnose the systematic sources of ...
Ali Mammadov
wiley +1 more source
Development of a Dynamic Multi-Parameter Prediction Model for the Maturation Process of '<i>Ugni Blanc</i>' Grapes Using Visible and Near-Infrared Spectroscopy. [PDF]
Su C +6 more
europepmc +1 more source
ABSTRACT In a business environment characterized by technological turbulence and an increasing societal demand for greater sustainability, companies seeking to enhance their growth are compelled to foster organizational cultures that promote continuous innovation.
José Bocoya‐Maline +2 more
wiley +1 more source
A dataset for geographical origin identification of tobacco leaves from multiple countries using near-infrared spectroscopy and chemometric analysis. [PDF]
Chen H +16 more
europepmc +1 more source
ABSTRACT The socio‐emotional wealth (SEW) perspective suggests that the specific priorities of a family business may make it more or less inclined to engage in sustainable practices. This paper examines how family business heterogeneity regarding family ownership, financial performance, and family board members affects the sustainability commitment of ...
Sonia Sánchez‐Andújar +2 more
wiley +1 more source
Label-Free Differentiation of Antimicrobial Resistance Groups Using Raman Spectroscopy. [PDF]
Pistiki A +7 more
europepmc +1 more source
Abstract Artificial intelligence and automation are no longer just buzzwords in the biopharmaceutical industry. The manufacturing of a class of biologics, comprising monoclonal antibodies, cell therapies, and gene therapies, is far more complex than that of traditional small molecule drugs.
Shyam Panjwani, Hao Wei, John Mason
wiley +1 more source

